ArticleJournal of clinical medicine2025

Predictors of Significant High-Sensitivity C-Reactive Protein Reduction After Use of Rosuvastatin/Amlodipine and Atorvastatin/Amlodipine-Subgroup Analysis in Randomized Controlled Trials.

Chun Muk Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.